ADC R&D Service Platform
BioDlink (TOT BIOPHARM) provides one-stop ADC R&D sample preparation and druggability study services, facilitating the streamlined progression of R&D from molecular screening to PCC (preclinical candidate compound) molecules. With a successful track record encompassing over all projects and employing various conjugation technologies, DAR value (Drug-to-Antibody Ratio) of the ADC molecules ranging from DAR2-8. Leveraging BioDlink (TOT BIOPHARM)'s sophisticated and rigorous analytical technology platform, we provide customers with tailored analysis and testing services to ensure the high-quality delivery of ADC molecules.
Service Contents
Linker
|
MC-GGFG
|
MC-VC-PABC
|
CL2A
|
МС
|
SMCC
|
|
Payload
|
Dxd
|
MMAE
|
SN38
|
MMAF
|
DM1
|
|
Conjugation Types
|
Cys conjugation
|
Cys conjugation
|
Cys conjugation
|
Cys conjugation
|
Lys conjugation
|
|
Service Advantages
◇ Experienced
– Over Hundred molecules with different conjugation methods have been successfully delivered
– The entire drug development value chain experience from early R&D to commercialization
– Over 10 Year industry experience of the team leader and core technicians
◇ mg to g level sample preparation
◇ Flexible project customization services, combined with analysis services, to ensure the quality of samples
◇ One-stop ADC service platform
– Seamless transition to subsequent CMC development or integrate into clinical stage
development and production, saving costs associated with vendor switches, and
achieving one-stop efficient development
Typical Case
Customer Request:Fast delivery of ADC R&D samples in 1 week.
Our Solution
-
Based on the platform method, expand conjugation development and the analysis in quick. After determining the conjugation conditions, proceed with ADC samples preparation.
-
Complete the rapid and efficient delivery of high-quality ADC samples within 1 week. Ensure sample purity >95%, strictly control the required DAR values, and guarantee minimal free drug residues.